Bots, Michiel L <br/><br/>
The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics.  [electronic resource] 

 -  Controlled clinical trials  Dec 2003 
 - 752-75 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0197-2456 
<br/><br/><label>Standard No.: </label>10.1016/s0197-2456(03)00096-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Bone Density--drug effects<br/>Carotid Arteries--diagnostic imaging<br/>Disease Progression<br/>Double-Blind Method<br/>Estrogens, Conjugated (USP)--pharmacology<br/>Female<br/>Humans<br/>Middle Aged<br/>Norpregnenes--pharmacology<br/>Osteoporosis--pathology<br/>Postmenopause--drug effects<br/>Random Allocation<br/>Randomized Controlled Trials as Topic--methods<br/>Surveys and Questionnaires<br/>Ultrasonography